Teva Pharmaceutical Indus...
21.00
0.56 (2.74%)
At close: Jan 14, 2025, 3:59 PM
21.35
1.64%
Pre-market Jan 15, 2025, 08:39 AM EST

Teva Pharmaceutical Industries Limited Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024
Distribution Service Revenue 390.00M 382.00M
Distribution Service Revenue Growth +2.09% n/a
License Revenue 45.00M 36.00M
License Revenue Growth +25.00% n/a
Product and Service, Other Revenue 102.00M 106.00M
Product and Service, Other Revenue Growth -3.77% n/a
Product Revenue 3.79B 3.64B
Product Revenue Growth +4.23% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Europe Revenue 4.84B 4.46B 4.81B 4.74B 4.77B 5.15B
Europe Revenue Growth +8.57% -7.32% +1.50% -0.71% -7.43% n/a
North America Revenue 8.12B 5.83B 6.39B 6.90B 6.94B 7.84B
North America Revenue Growth +39.25% -8.76% -7.36% -0.56% -11.44% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 924.00M 939.00M 886.00M 902.00M 844.00M 910.00M 842.00M 838.00M 822.00M 907.00M 880.00M 908.00M 888.00M 857.00M 875.00M 1.01B 884.00M 861.00M 917.00M 1.02B 880.00M 962.00M 940.00M 1.14B 1.05B 1.03B 1.10B 1.36B 1.19B 1.23B 1.21B 1.44B 1.25B 1.26B 1.14B 1.21B 1.10B 1.19B 1.23B
Selling, General, and Administrative Revenue Growth -1.60% +5.98% -1.77% +6.87% -7.25% +8.08% +0.48% +1.95% -9.37% +3.07% -3.08% +2.25% +3.62% -2.06% -13.37% +14.25% +2.67% -6.11% -10.45% +16.36% -8.52% +2.34% -17.62% +8.46% +2.53% -6.73% -18.94% +14.03% -3.41% +2.07% -16.18% +15.20% -1.03% +10.50% -5.30% +10.13% -7.51% -3.58% n/a
Research and Development Revenue 240.00M 269.00M 242.00M 227.00M 253.00M 240.00M 234.00M 210.00M 175.00M 228.00M 225.00M 244.00M 222.00M 248.00M 254.00M 293.00M 258.00M 225.00M 221.00M 232.00M 240.00M 276.00M 261.00M 295.00M 311.00M 290.00M 317.00M 360.00M 545.00M 486.00M 457.00M 684.00M 663.00M 375.00M 389.00M 446.00M 361.00M 386.00M 332.00M
Research and Development Revenue Growth -10.78% +11.16% +6.61% -10.28% +5.42% +2.56% +11.43% +20.00% -23.25% +1.33% -7.79% +9.91% -10.48% -2.36% -13.31% +13.57% +14.67% +1.81% -4.74% -3.33% -13.04% +5.75% -11.53% -5.14% +7.24% -8.52% -11.94% -33.94% +12.14% +6.35% -33.19% +3.17% +76.80% -3.60% -12.78% +23.55% -6.48% +16.27% n/a
Sales and Marketing Revenue 626.00M 656.00M 608.00M 610.00M 576.00M 603.00M 546.00M 549.00M 539.00M 594.00M 584.00M 632.00M 597.00M 615.00M 585.00M 683.00M 605.00M 597.00M 613.00M 706.00M 595.00M 666.00M 648.00M 797.00M 743.00M 710.00M 771.00M 865.00M 860.00M 960.00M 971.00M 1.13B 940.00M 952.00M 839.00M 916.00M 780.00M 860.00M 922.00M
Sales and Marketing Revenue Growth -4.57% +7.89% -0.33% +5.90% -4.48% +10.44% -0.55% +1.86% -9.26% +1.71% -7.59% +5.86% -2.93% +5.13% -14.35% +12.89% +1.34% -2.61% -13.17% +18.66% -10.66% +2.78% -18.70% +7.27% +4.65% -7.91% -10.87% +0.58% -10.42% -1.13% -13.99% +20.11% -1.26% +13.47% -8.41% +17.44% -9.30% -6.72% n/a